UNUSUAL CASE OF THIAMINE RESPONSIVE MEGALOBLASTIC ANEMIA

Authors

  • Faten Tinsa Department of pediatrics B of the children's hospital of Tunis
  • Saadia Ben Amor Department of pediatrics B of the children's hospital of Tunis
  • Naziha Kaabachi Department of pediatrics B of the children's hospital of Tunis
  • Mehdi Ben Lasouad Department of pediatrics B of the children's hospital of Tunis
  • Khadija Boussetta Department of pediatrics B of the children's hospital of Tunis
  • Souad Bousnina Department of pediatrics B of the children's hospital of Tunis

Keywords:

child, diabetes, thiamine responsive megaloblastic anemia, respiratory chain deficiency

Abstract

Background: Thiamine- responsive megaloblastic anemia syndrome is a rare autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and neurosensoriel deafness, responding in varying degrees to thiamine treatment.
Aim: Report an unusual case of this rare disorder
Case report: We report the case of a four-year-old boy who presented unusual features of thiamine- responsive megaloblastic anemia. In addition to the typical triad of the syndrome, he presented leuconeutropenia, hepatosplenomegalia, cardiac abnormalities including absent P waves, mitral and tricuspid insufficiency, retinitis pigmentosa, nystagmus, developmental delay and a brain Magnetic resonance imaging ischemic lesion. Lactate levels in serum and the lactate/ pyruvate ratio were increased. The mitochondrial mutation m.3243A>G located in MTTL1 gene encoding for transfer RNA leucine (tRNALeu(UUR)) was not found . Treatment with thiamine resulted in normalisation of the haemoglobin level, white cell count, and glucose and lactate levels. On three years follow up, the patient did not need insulinotherapy.
Conclusion: These data sign the crucial role that thiamine plays for many cells and tissues and its importance in the activity of the respiratory chain.

Downloads

Download data is not yet available.

References

Rogers LE, Porter FS , Sidbury JB, Thiamine-responsive megaloblastic anemia. J Ped 1969;74: 494-504.

Fleming JC, Tartaglini E, Steinkamp MP, et al. The gene mutated in thiamine responsive anemia with diabetes and deafness encodes a functional thiamine transporter. Nat Genet 1999; 22: 305-308.

Labay V, Raz T, Baron D, et al . Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet 1999; 22: 300-304.

Bazarbachi A, Muakkit S, Ayas M, et al. Thiamine-responsive myelodysplasia. Br J Haematol 1998; 104 :1098-1100.

Gritli S, Omar S, Tartaglini E, et al. A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine- responsive megaloblastic anaemia, diabetes and deafness syndrome. Br J Haematol 2001; 113:508-513.

Ganapathy V, Smith SB, Prasad PD. SLC19: the folate/thiamine transporter family. Pflugers Arch 2004; 447:641-6.

Barrett TG, Poulton K, Baines M, McCowen C. Muscle biochemistry in thiamin-responsive anaemia. J Inher Metab Dis 1997; 20: 404-6.

Stagg AR, Fleming JC, Baker MA, et al. Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. J Clin Invest 1999; 103: 723-9.

Alzahrani AS, Baitei E, Zou M, Shi Y. Thiamine transporter mutation: an example of monogenic diabetes mellitus. Eur J Endocrinol 2006; 155: 787-792.

Villa V, Rivellese A, Di Salle F, et al. Acute ischemic in a young woman with the thiamine-responsive megaloblastic anemia syndrome. J Clin Endocrinol Metab 2000; 85: 947-949.

Bappal B, Nair R, Shaikh H, et al. Five years follow up of diabetes mellitus in two siblings with thiamine responsive megaloblastic anemia. Indian Pediatr 2001; 38: 1295-1298.

Ricketts CJ, Minton JA, Samuel J, et al. Thiamine-responsive megaloblastic anaemia syndrome: Long-term follow-up and mutation analysis of seven families. Acta Paediatr 2006; 95: 99-104.

Lober A, Gazit AZ, Khoury A, Schwartz Y, et al. Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome. Pediatr Cardiol 2003; 24: 476-48.

Subramanian VS, Mohammed ZM, Molina A, et al. Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation. J Physiol 2007; 582: 73-85.

Ho J, Mah JK, Hill MD. Pediatric stroke associated with new onset type 1 diabetes mellitus: case reports and review of the literature. Pediatr Diabetes 2006; 7 :116-121.

Scharfe C, Hauschild M, Klopstock T, et al. A novel mutation in the thiamine responsive megaloblastic anemia gene SLC19A2 in a patient with deficiency of respiratory chain complexI. J Med Genet 2000; 37 :669-673.

Van den Ouweland JMW, Lemkes HHPJ, Ruittenbeek W, et al. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992; 1: 368-71.

Reardon W, Ross RJM, Sweeney MG, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992; 340:1376-9.

Hasuo P, Tamura S, Yasumori K, et al. Computed tomography and angiography in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes); report of 3 cases. Neuroradiology 1987; 29:393-397.

Downloads

Issue

Section

Case report

Categories